SCHEMBL21716463

SCHEMBL21716463

c1ccc2cc3c(cc2c1)c1ccccc1n3-c1ccc2c3cc4ccccc4cc3n(-c3nc4ccccc4nc3-c3ccc4c(ccc5ccccc54)c3)c2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 2/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34
TUBA1C Q9BQE3 1/20 0.34
TUBB6 Q9BUF5 1/20 0.34
TUBB2B Q9BVA1 1/20 0.34
TUBB1 Q9H4B7 1/20 0.34
GSR P00390 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716913 1.00 MAPK10 (0.34) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL22425486 0.97 TUBB4A (0.37) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL21213631 0.94 TUBB4A (0.37) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL21716970 0.94 GSR (0.32) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL21717011 0.94 PDPK1 (0.34) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL22425676 0.92 TUBB4A (0.37) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL21716926 0.92 TUBB4A (0.37) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL21716783 0.92 TUBB4A (0.37) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL23471680 0.92 MAPK10 (0.33) MAPK10MAPK8MAPK9TUBB4ATUBB
SCHEMBL21716930 0.91 HPGD (0.33) MAPK10MAPK8MAPK9TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 MAPK10 1751/4885MAPK8 1985/4885MAPK9 1041/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 MAPK10 1751/4885MAPK8 1985/4885MAPK9 1041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.